Page 1

Sensus Healthcare TECHNOLOGY THAT CARES Exhibit 99.1 Sensus Healthcare Reports Second Quarter 2021 Financial Results Revenues of $ 5.4 million up 358 % year - over - year , up 77 % sequentially Conference call begins at 4:30 p.m. Eastern time today BOCA RATON , Fla . ( August 5 , 2021 ) - Sensus Healthcare , Inc. ( Nasdaq : SRTS ) , a medical device company specializing in highly effective , non - invasive , minimally - invasive and cost - effective treatments for oncological and non - oncological conditions , announces financial results for the three and six months ended June 30 , 2021 . Highlights from the second quarter of 2021 and recent weeks include the following ( all comparisons are with the second quarter of 2020 , unless otherwise indicated ) : • Shipped 17 systems during the quarter , including four to China and 13 domestic • Worldwide installed base of SRT systems as of June 30 , 2021 was 515 systems • Revenues were $ 5.4 million , up 358 % over the second quarter of 2020 and up 77 % over the first quarter of 2021 • Net loss narrowed to $ ( 0.3 ) million , or $ ( 0.02 ) per share , from a net loss of $ ( 2.6 ) million , or $ ( 0.16 ) per share • Adjusted EBITDA , a non - GAAP financial measure , narrowed to $ ( 0.1 ) million from $ ( 2.3 ) million • Cash and cash equivalents were $ 15.2 million as of June 30 , 2021 compared with $ 14.9 million as of December 31 , 2020 due in part to a reduction in expenses • Sales team almost back to full force as we continue to add headcount anticipating second half growth Management Commentary " Our second quarter financial results reflect significant improvement following the impact of COVID - 19 on the business during 2020 , in particular last year's second quarter , as overall market conditions continued to improve toward pre - pandemic levels , " said Joe Sardano , chairman and chief executive officer of Sensus Healthcare . " Our business gained momentum throughout the first half of the year and we are cautiously optimistic about sequential quarterly growth for the rest of 2021. We shipped 17 systems during the second quarter , including seven SRT - 100 Vision systems . We sold six SRT - 100 Visions to our corporate account and 11 SRT Systems directly to customers . New CMS reimbursement schedules for SRT treatments along with new Leasing options provides for a better ROI for our customers as patients continue to request a non - invasive approach to treating their skin cancer . " Volumes for SRT Systems installed at customer sites have continued to improve since the Centers for Medicare & Medicaid Services revalued our main procedure and other codes upward effective January 1st of this year . In addition , various medical associations such as the American Academy of Dermatology and the American Society for Radiation Oncology have increased their support for the safety and efficacy of SRT to treat non - melanoma skin cancer and keloids via conference presentations and papers , and we believe this support is resonating with physicians . The combination of backing by key opinion leaders and our presence at important trade shows such as the Fall Clinical has generated a solid list of leads that we expect to convert to sales during the third quarter and beyond . We look forward to attending the Fall Clinical in Las Vegas in October , which will be held both live and virtually this year . " We are very pleased with the continued success of our international business , " Mr. Sardano added . “ Our new distributor for China ( Asia ) and Hong Kong has developed an extensive network of prospects that are converting to sales , with four more systems shipped to China during the second quarter . To date in 2021 we sold five systems to China , in addition to four sold during the fourth quarter of 2020. We are now expanding our focus to India for further international growth and are hopeful to record our first sale there later this year . " The integration of our Sentinel ™ IT Solutions software into our proprietary lasers is complete and these lasers are now available through Sensus Laser Aesthetic Solutions ( SLAS ) , our mobile aesthetic laser division serving dermatologists throughout Florida with plans to expand beyond . SLAS offers multiple lasers with custom rental options . Sentinel provides asset management and HIPAA - compliant patient data and storage capability , and also contains the software necessary to support shared service models including direct patient billing . We have been actively evaluating an expansion to our mobile aesthetic laser business beyond Florida via strategic transactions in geographies where we have an existing SRT customer base . " Barring any new economic restrictions related to COVID - 19 or inflation in the U.S. , we are confident we will deliver higher revenues as well as Adjusted EBITDA throughout the balance of the year , " Mr. Sardano concluded . We are clearly on track to profitability . The entire Sensus Team is committed to realizing this goal ! " Second Quarter Financial Results Revenues for the second quarter of 2021 were $ 5.4 million compared with $ 1.2 million for the second quarter of 2020. The 358 % increase was primarily driven by a higher number of units sold in 2021 , service revenue on installed units and the impact of COVID - 19 on the second quarter of 2020 . Cost of sales for the second quarter of 2021 was $ 2.1 million compared with $ 0.5 million for the prior - year quarter . The increase was due to higher sales in the 2021 period . Gross profit for the second quarter of 2021 was $ 3.3 million compared with $ 0.6 million for the second quarter of 2020. Gross margin for the second quarter of 2021 was 61.7 % compared with 54.1 % for the prior - year quarter . The increase in gross margin was primarily driven by the higher number of units sold in 2021 , service revenue on installed units and the impact of COVID - 19 on the 2020 quarter Selling and marketing expense for the second quarter of 2021 was $ 1.3 million compared with $ 1.2 million for the second quarter of 2020. The increase was primarily due to higher commission expense offset by a reduction in headcount .